QRG Capital Management Inc. lowered its position in UBS Group AG (NYSE:UBS – Free Report) by 3.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 393,517 shares of the bank’s stock after selling 16,163 shares during the quarter. QRG Capital Management Inc.’s holdings in UBS Group were worth $12,164,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. Drive Wealth Management LLC raised its stake in shares of UBS Group by 3.2% during the 2nd quarter. Drive Wealth Management LLC now owns 11,100 shares of the bank’s stock worth $328,000 after purchasing an additional 349 shares in the last quarter. Rosenberg Matthew Hamilton lifted its stake in UBS Group by 15.6% during the third quarter. Rosenberg Matthew Hamilton now owns 2,624 shares of the bank’s stock worth $81,000 after purchasing an additional 355 shares during the period. D Orazio & Associates Inc. boosted its stake in shares of UBS Group by 3.5% in the 1st quarter. D Orazio & Associates Inc. now owns 11,264 shares of the bank’s stock valued at $346,000 after purchasing an additional 381 shares in the last quarter. Parallel Advisors LLC grew its position in UBS Group by 2.6% during the 2nd quarter. Parallel Advisors LLC now owns 16,552 shares of the bank’s stock worth $489,000 after acquiring an additional 420 shares during the last quarter. Finally, Traveka Wealth LLC increased its position in UBS Group by 6.2% in the 2nd quarter. Traveka Wealth LLC now owns 7,466 shares of the bank’s stock valued at $221,000 after acquiring an additional 435 shares in the last quarter.
Analysts Set New Price Targets
UBS has been the topic of several analyst reports. Bank of America initiated coverage on shares of UBS Group in a report on Thursday, September 19th. They issued a “neutral” rating on the stock. StockNews.com raised shares of UBS Group from a “hold” rating to a “buy” rating in a research note on Friday. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.
UBS Group Trading Down 0.3 %
Shares of NYSE UBS opened at $31.01 on Tuesday. The stock has a market cap of $99.43 billion, a P/E ratio of 25.84 and a beta of 1.15. The firm has a 50 day moving average price of $30.88 and a two-hundred day moving average price of $30.26. The company has a debt-to-equity ratio of 3.87, a quick ratio of 1.05 and a current ratio of 1.05. UBS Group AG has a 52-week low of $24.07 and a 52-week high of $32.90.
UBS Group (NYSE:UBS – Get Free Report) last issued its earnings results on Wednesday, October 30th. The bank reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15. The company had revenue of $19.31 billion for the quarter, compared to analysts’ expectations of $11.20 billion. UBS Group had a return on equity of 4.69% and a net margin of 5.13%. During the same period last year, the business earned ($0.24) EPS. As a group, equities analysts forecast that UBS Group AG will post 1.45 EPS for the current year.
UBS Group Profile
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions.
See Also
- Five stocks we like better than UBS Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- Intel: Is Now the Time to Be Brave?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding UBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UBS Group AG (NYSE:UBS – Free Report).
Receive News & Ratings for UBS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS Group and related companies with MarketBeat.com's FREE daily email newsletter.